Filing Details
- Accession Number:
- 0001093557-25-000212
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-17 17:33:16
- Reporting Period:
- 2025-06-13
- Filing Date:
- 2025-06-17
- Accepted Time:
- 2025-06-17 17:33:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238485 | Nicholas Augustinos | 6340 Sequence Drive San Diego CA 92121 | Yes | No | No | No |
Transaction Summary
Sold: | 6,290 shares | Avg. Price: $82.34 | Total Value: $517,906.02 |
Number of Shares After Transactions: | 33,411 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-06-13 | 2,618 | $81.69 | 37,083 | No | 4 | S | Indirect | by Trust |
Common Stock | Disposition | 2025-06-16 | 3,672 | $82.80 | 33,411 | No | 4 | S | Indirect | by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | by Trust |
No | 4 | S | Indirect | by Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,046 | Direct |
Footnotes
- On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee.
- Included in this number are 5,046 unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.